Ameriprise
ARA

Ameriprise’s American Renal Associates Holdings, Inc ARA Stock Holding History

Ameriprise’s Portfolio ARA Stock Details ARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-33,945
Closed -$640K – 3732
2018
Q1 		$640K Buy
+33,945
New +$670K ﹤0.01% 3141

Other funds holding ARA

CP
Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WIC
Whitegate Investment Counselors Concord, New Hampshire $351M AUM 16.12% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ameriprise's ARA Position: Q2 2018 in Review

Ameriprise sold out of American Renal Associates Holdings, Inc (ARA) in Q2 2018, closing a stake of 33,945 shares — an estimated $640K sold.

Ameriprise first reported a position in ARA in Q1 2018 and held it in 1 quarter. The position peaked at $640K in Q1 2018. 80 funds tracked by Wall St. Rank hold ARA as of Q2 2018.

  • Ameriprise reported no remaining American Renal Associates Holdings, Inc position as of Q2 2018 after selling out during the quarter.
  • Ameriprise sold 33,945 American Renal Associates Holdings, Inc shares in Q2 2018, an estimated $640K.
  • Ameriprise first reported a position in American Renal Associates Holdings, Inc in Q1 2018 and held it in 1 quarter.
  • Ameriprise's American Renal Associates Holdings, Inc position peaked at $640K in Q1 2018.
  • 80 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q2 2018.

Based on Ameriprise's 13F filing for Q2 2018, filed 14 Aug 2018.